These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 27108266)

  • 1. Solid lipid nanoparticles containing 7-ethyl-10-hydroxycamptothecin (SN38): Preparation, characterization, in vitro, and in vivo evaluations.
    Mosallaei N; Mahmoudi A; Ghandehari H; Yellepeddi VK; Jaafari MR; Malaekeh-Nikouei B
    Eur J Pharm Biopharm; 2016 Jul; 104():42-50. PubMed ID: 27108266
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lipid nanoparticles loaded with 7-ethyl-10-hydroxycamptothecin-phospholipid complex: in vitro and in vivo studies.
    Liu H; Lu H; Liao L; Zhang X; Gong T; Zhang Z
    Drug Deliv; 2015; 22(6):701-9. PubMed ID: 24625262
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SN38 polymeric nanoparticles: in vitro cytotoxicity and in vivo antitumor efficacy in xenograft balb/c model with breast cancer versus irinotecan.
    Sepehri N; Rouhani H; Tavassolian F; Montazeri H; Khoshayand MR; Ghahremani MH; Ostad SN; Atyabi F; Dinarvand R
    Int J Pharm; 2014 Aug; 471(1-2):485-97. PubMed ID: 24879937
    [TBL] [Abstract][Full Text] [Related]  

  • 4. BR2 and CyLoP1 enhance in-vivo SN38 delivery using pegylated PAMAM dendrimers.
    Mahmoudi A; Jaafari MR; Ramezanian N; Gholami L; Malaekeh-Nikouei B
    Int J Pharm; 2019 Jun; 564():77-89. PubMed ID: 30991135
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dual 7-ethyl-10-hydroxycamptothecin conjugated phospholipid prodrug assembled liposomes with in vitro anticancer effects.
    Du Y; Zhang W; He R; Ismail M; Ling L; Yao C; Fu Z; Li X
    Bioorg Med Chem; 2017 Jun; 25(12):3247-3258. PubMed ID: 28465086
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nanoparticle delivery of an SN38 conjugate is more effective than irinotecan in a mouse model of neuroblastoma.
    Iyer R; Croucher JL; Chorny M; Mangino JL; Alferiev IS; Levy RJ; Kolla V; Brodeur GM
    Cancer Lett; 2015 May; 360(2):205-12. PubMed ID: 25684664
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis, characterization, and antitumor evaluation of the albumin-SN38 conjugate.
    Yao Y; Su X; Xie Y; Wang Y; Kang T; Gou L; Yi C; Yang J
    Anticancer Drugs; 2013 Mar; 24(3):270-7. PubMed ID: 23233044
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A nanotherapeutic strategy to overcome chemoresistance to irinotecan/7-ethyl-10-hydroxy-camptothecin in colorectal cancer.
    Huang Q; Liu X; Wang H; Liu X; Zhang Q; Li K; Chen Y; Zhu Q; Shen Y; Sui M
    Acta Biomater; 2022 Jan; 137():262-275. PubMed ID: 34718178
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of two self-assembled macromolecular prodrug micelles with different conjugate positions of SN38 for enhancing antitumor activity.
    Liu Y; Piao H; Gao Y; Xu C; Tian Y; Wang L; Liu J; Tang B; Zou M; Cheng G
    Int J Nanomedicine; 2015; 10():2295-311. PubMed ID: 25848251
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization and stability of nanostructured lipid carriers as drug delivery system.
    Abbasalipourkabir R; Salehzadeh A; Abdullah R
    Pak J Biol Sci; 2012 Feb; 15(3):141-6. PubMed ID: 22866544
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Docetaxel-loaded solid lipid nanoparticles: preparation, characterization, in vitro, and in vivo evaluations.
    Mosallaei N; Jaafari MR; Hanafi-Bojd MY; Golmohammadzadeh S; Malaekeh-Nikouei B
    J Pharm Sci; 2013 Jun; 102(6):1994-2004. PubMed ID: 23558514
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intracellular target delivery of 10-hydroxycamptothecin with solid lipid nanoparticles against multidrug resistance.
    Liu M; Chen D; Wang C; Chen X; Wen Z; Cao Y; He H
    J Drug Target; 2015; 23(9):800-5. PubMed ID: 25766079
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SN38-loaded <100 nm targeted liposomes for improving poor solubility and minimizing burst release and toxicity: in vitro and in vivo study.
    Fang YP; Chuang CH; Wu YJ; Lin HC; Lu YC
    Int J Nanomedicine; 2018; 13():2789-2802. PubMed ID: 29785106
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis of novel polymeric nanoparticles (methoxy-polyethylene glycol-chitosan/hyaluronic acid) containing 7-ethyl-10-hydroxycamptothecin for colon cancer therapy:
    Sharifi F; Jahangiri M; Ebrahimnejad P
    Artif Cells Nanomed Biotechnol; 2021 Dec; 49(1):367-380. PubMed ID: 33851564
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel lipophilic SN38 prodrug forming stable liposomes for colorectal carcinoma therapy.
    Xing J; Zhang X; Wang Z; Zhang H; Chen P; Zhou G; Sun C; Gu N; Ji M
    Int J Nanomedicine; 2019; 14():5201-5213. PubMed ID: 31371956
    [No Abstract]   [Full Text] [Related]  

  • 16. SN38 loaded nanostructured lipid carriers (NLCs); preparation and in vitro evaluations against glioblastoma.
    Shirazi AS; Varshochian R; Rezaei M; Ardakani YH; Dinarvand R
    J Mater Sci Mater Med; 2021 Jun; 32(7):78. PubMed ID: 34191134
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Brain targeting effect of camptothecin-loaded solid lipid nanoparticles in rat after intravenous administration.
    Martins SM; Sarmento B; Nunes C; Lúcio M; Reis S; Ferreira DC
    Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt A):488-502. PubMed ID: 23994244
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Redox responsive 7-ethyl-10-hydroxycamptothecin (SN38) lysophospholipid conjugate: synthesis, assembly and anticancer evaluation.
    He W; Du Y; Wang T; Wang J; Cheng L; Li X
    Int J Pharm; 2021 Sep; 606():120856. PubMed ID: 34229071
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel anti-tumor strategy: PEG-hydroxycamptothecin conjugate loaded transferrin-PEG-nanoparticles.
    Hong M; Zhu S; Jiang Y; Tang G; Sun C; Fang C; Shi B; Pei Y
    J Control Release; 2010 Jan; 141(1):22-9. PubMed ID: 19735683
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preparation and cytotoxicity of 2-methoxyestradiol-loaded solid lipid nanoparticles.
    Guo X; Xing Y; Mei Q; Zhang H; Zhang Z; Cui F
    Anticancer Drugs; 2012 Feb; 23(2):185-90. PubMed ID: 22027535
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.